Heidelberg Pharma AG, DE000A11QVV0

Heidelberg Pharma AG, DE000A11QVV0

23.06.2022 - 12:45:22

Heidelberg Pharma AG: Correction of a release from 17/03/2022 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Name: Heidelberg Pharma AG Street: Gregor-Mendel-Str. 22 Postal code: 68526 City: LadenburgGermany Legal Entity Identifier (LEI): 391200E09XYBYITR1W32 2. Reason for notification ? Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments ? Change of breakdown of voting rights X Other reason:Conclusion of a pool agreement 3. Details of person subject to the notification obligation Natural person (first name, surname): Christof HettichDate of birth: 05 Nov 1959 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.dievini Hopp BioTech holding GmbH & Co. KGDH-LT-Investments GmbH 5. Date on which threshold was crossed or reached: 13 March 2022 6. Total positions ? % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 28.80 % 2.49 % 28.80 % 34175809 Previous notification n/a % n/a % n/a % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In % ? Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000A11QVV0 0 9843498 0.00 % 28.80 % Total 9843498 28.80 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0.00 % ? ? Total 0 0.00 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % Share transfer agreement n/a n/a n/a 850517 2.49 % ? ? ? Total 850517 2.49 % 8. Information in relation to the person subject to the notification obligation? Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) -Herr Christof Hettich % % % -4H invest GmbH 28.80 % % 28.80 % 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks:Accession of 4H invest GmbH to the pool agreement between dievini Hopp BioTech holding GmbH & Co. KG, DH-LT-Investments GmbH, MH-LT-Investments GmbH. The instruments specified under 7.b.2 relate to voting rights shares which are already attributed to 4H invest GmbH by joining the pool agreement (7.a); therefore, no addition is made under 6. (Total voting rights) no addition of the sum 7.a + 7.b. ? Date22 Jun 2022

23.06.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: Heidelberg Pharma AG Gregor-Mendel-Str. 22 68526 Ladenburg

Germany Internet: www.heidelberg-pharma.com ? End of News DGAP News Service

1382541??23.06.2022?

@ dgap.de